S. Eberle

Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.

J. Brachmann, M. Schindewolf, P. Dohmen, 2017, Journal of the American College of Cardiology.

Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.

J. Brachmann, M. Schindewolf, P. Dohmen, 2014, Thrombosis research.

Diagnosis of deep-vein thrombosis: Adherence to guidelines and outcomes in real-world health care

H. Riess, V. Hach-Wunderle, S. Schellong, 2009, Thrombosis and Haemostasis.

Distribution of angiographic measures of restenosis after drug-eluting stent implantation

A. Kastrati, J. Mehilli, A. Schömig, 2009, Heart.

Impact of gender on the clinical presentation and diagnosis of deep-vein thrombosis

H. Riess, V. Hach-Wunderle, S. Schellong, 2010, Thrombosis and Haemostasis.

Post-thrombotic syndrome 3 years after deep venous thrombosis in the Thrombosis and Pulmonary Embolism in Out-Patients (TULIPA) PLUS Registry.

H. Riess, V. Hach-Wunderle, S. Schellong, 2013, Journal of vascular surgery. Venous and lymphatic disorders.

Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP)

U. Scholz, J. Koscielny, C. Dempfle, 2021, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Advances in ITP – Therapy and Quality of Life – A Patient Survey

S. Hummler, H. Ostermann, A. Salama, 2011, PloS one.

Prevalence of low‐risk and high‐risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: An epidemiological observational study

W. Quint, T. Iftner, N. Banik, 2010, Journal of medical virology.

Statistical Methods to Identify Predictive Factors

K. Ulm, M. Kriner, S. Eberle, 2005 .

Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials.

Kurt Ulm, Adnan Kastrati, Albert Schömig, 2005, JAMA.

Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.

J. Brachmann, M. Schindewolf, P. Dohmen, 2014, Thrombosis research.